BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24418002)

  • 1. Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system.
    Matsumoto T; Lopes RA; Taguchi K; Kobayashi T; Tostes RC
    Life Sci; 2014 Nov; 118(2):129-35. PubMed ID: 24418002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.
    Carrillo-Sepulveda MA; Matsumoto T; Nunes KP; Webb RC
    Acta Physiol (Oxf); 2014 May; 211(1):20-35. PubMed ID: 24640957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications.
    Campia U; Tesauro M; Di Daniele N; Cardillo C
    Life Sci; 2014 Nov; 118(2):149-55. PubMed ID: 24607780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.
    Chakrabarti S; Khan ZA; Cukiernik M; Fukuda G; Chen S; Mukherjee S
    Int J Exp Diabetes Res; 2002; 3(4):217-31. PubMed ID: 12546275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells.
    Frank HJ; Levin ER; Hu RM; Pedram A
    Endocrinology; 1993 Sep; 133(3):1092-7. PubMed ID: 8365355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of endothelin-1 for microvascular dysfunction in diabetes.
    Kalani M
    Vasc Health Risk Manag; 2008; 4(5):1061-8. PubMed ID: 19183753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction.
    Sorrentino FS; Matteini S; Bonifazzi C; Sebastiani A; Parmeggiani F
    Eye (Lond); 2018 Jul; 32(7):1157-1163. PubMed ID: 29520046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus.
    Pernow J; Shemyakin A; Böhm F
    Life Sci; 2012 Oct; 91(13-14):507-16. PubMed ID: 22483688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide and endothelin in endothelial maintenance of vasoconstrictor responses in aortas of diabetic female rats.
    Sartoretto SM; Santos-Eichler R; de Cássia A Tostes R; Carvalho MH; Akamine EH; Fortes ZB
    J Diabetes; 2013 Jun; 5(2):197-206. PubMed ID: 23061464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in diabetes mellitus.
    Cosentino F; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction - a major mediator of diabetic vascular disease.
    Sena CM; Pereira AM; Seiça R
    Biochim Biophys Acta; 2013 Dec; 1832(12):2216-31. PubMed ID: 23994612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin: emerging role in diabetic vascular complications.
    Hopfner RL; Gopalakrishnan V
    Diabetologia; 1999 Dec; 42(12):1383-94. PubMed ID: 10651255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 and diabetic complications: focus on the vasculature.
    Ergul A
    Pharmacol Res; 2011 Jun; 63(6):477-82. PubMed ID: 21292003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin in diabetic vascular complications.
    Lam HC
    Endocrine; 2001 Apr; 14(3):277-84. PubMed ID: 11444423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endothelins and their receptors in heart failure.
    Giannessi D; Del Ry S; Vitale RL
    Pharmacol Res; 2001 Feb; 43(2):111-26. PubMed ID: 11243712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
    Potenza MA; Gagliardi S; Nacci C; Carratu' MR; Montagnani M
    Curr Med Chem; 2009; 16(1):94-112. PubMed ID: 19149564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenic protein-4-induced oxidant signaling via protein carbonylation for endothelial dysfunction.
    Wong CM; Zhang Y; Huang Y
    Free Radic Biol Med; 2014 Oct; 75():178-90. PubMed ID: 25091895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between the plasma levels of endothelin and angiopathy in diabetic patients].
    Zeng ZP; Tang D; Sun ML
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):467-9. PubMed ID: 7867443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin in the cardiovascular system.
    Rodríguez-Pascual F; Busnadiego O; Lagares D; Lamas S
    Pharmacol Res; 2011 Jun; 63(6):463-72. PubMed ID: 21296157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.